Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
- J. B. Lesesne, N. Rothschild, +7 authors P. Schein
- Medicine
- Journal of clinical oncology : official journal…
- 1 June 1989
A registry of suspected cases of cancer-associated hemolytic-uremic syndrome (C-HUS) was established in May 1984. Records of 85 patients from the registry, all with history of cancer, hematocrit less… Expand
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
- J. Macdonald, P. Schein, +8 authors C. Lagarde
- Medicine
- Annals of internal medicine
- 1 October 1980
Sixty-two patients with advanced measurable gastric cancer were treated with a combination chemotherapy program of 5-fluorouracil, doxorubicin, and mitomycin (FAM). Forty-two percent of patients… Expand
Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
- B. Ardalan, M. Buscaglia, P. Schein
- Chemistry, Medicine
- Biochemical pharmacology
- 1978
The antitumor activity of 5-fluoruoracil (5-FU) for two murine colonie adenocarcinomas was correlated with the concentration and the clearance of the active antimetabolite, 5-fluorodeoxyuridylate… Expand
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE: RESULTS WITH COMBINATION CHEMOTHERAPY
- V. Devita, G. Canellos, B. Chabner, P. Schein, R. Young
- Medicine
- The Lancet
- 1 February 1975
Twenty-seven patients with advanced diffuse histiocytic lymphoma (reticulum-cell sarcoma) were treated with combination chemotherapy utilising nitrogen mustard (or cyclophosphamide), procarbazine,… Expand
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.
- M. Lutzner, R. Edelson, P. Schein, I. Green, C. Kirkpatrick, A. Ahmed
- Medicine
- Annals of internal medicine
- 1 October 1975
Substantial evidence has accumulated to indicate not only that mycosis fungoides and the Sézary syndrome are closely related malignancies, but to suggest that they are part of a larger spectrum of… Expand
Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.
Fifteen of 52 patients (29%) with diffuse histiocytic and undifferentiated pleomorphic lymphoma developed central nervous system (CNS) complications, primarily leptomeningeal lymphoma. Lumbar… Expand
Gastrointestinal toxicity of chemotherapeutic agents.
- E. Mitchell, P. Schein
- Medicine
- Seminars in oncology
- 1 February 2006
Chemotherapy-induced toxicities commonly occur in sites within the gastrointestinal (GI) tract and account for dose-limiting effects. These toxicities are major contributing factors to dose… Expand
A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma
- P. Schein
- Medicine
- Cancer
- 1 May 1982
This controlled trial compared the survival of 90 patients with locally advanced gastric carcinoma treated with either chemotherapy alone (5‐FU and methyl‐CCNU) or external radiotherapy of 5000 rad… Expand
The use of drugs in combination for the treatment of cancer: rationale and results.
INTEREST in the use of drugs in combination tor the treatment of cancer is not a new phenomenon. It stems from the inability to obtain entirely satisfactory results when available agents are given ...
5‐fluorouracil, adriamycin, and mitomycin‐c (fam) combination chemotherapy in the treatment of advanced gastric cancer
- J. Macdonald, P. Woolley, T. Smythe, W. Ueno, D. Hoth, P. Schein
- Medicine
- Cancer
- 1 July 1979
Thirty‐six patients with advanced measurable gastric cancer were treated with a new combination chemotherapy program consisting of 5‐fluorouracil, Adriamycin and mitomycin‐C (FAM). Fifty percent of… Expand